Evidence map›Paper›PMID 33329908›Full record

ArticleSafety and health at work2020

Follow-up of Soluble Mesothelin-Related Protein Levels in Participants With Asbestos-Related Disorders.

Eun-Kee Park, Anthony R Johnson, Donald Wilson, Paul S Thomas, Deborah H Yates

Open access · goldAbstract read
In one paragraph

Article in Safety and health at work, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Eun-Kee ParkDepartment of Medical Humanities and Social Medicine, College of Medicine, Kosin University, Busan, Republic of Korea.
Anthony R JohnsonDepartment of Respiratory Medicine, Liverpool Hospital, Sydney, New South Wales, Australia.
Donald WilsonDepartment of Public Health and Primary Care, College of Medicine, Nursing and Health Sciences, Fiji National University, Fiji.
Paul S ThomasSchool of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Deborah H YatesDepartment of Thoracic Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.
Fiji National University · FJKosin University · KRLiverpool Hospital · AUSt Vincent's Hospital Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsbestos exposure is associated with the development of the cancer malignant mesothelioma (MM). Measurement of soluble mesothelin-related protein (SMRP) has been suggested as a method for detection of MM in its early stages. We prospectively examined SMRP levels in participants with asbestos exposure who are a group at a high risk of development of MM.

methodsThis study was a follow-up of our cohort of 322 asbestos-exposed participants. No further participants developed MM or malignancy over the study period. Mean follow-up time was 22.9 months.

resultsMean (standard deviation) SMRP levels at baseline and follow-up were 0.94 (0.79) and 0.91 (0.86) nmol/L (

conclusionMonitoring programs for early detection of MM need to take into account increased SMRP levels found in benign asbestos-related diseases.

Indexed as

Asbestos-related disordersBiomarkerFollow-upSMRP

Identifiers

PMID33329908
PMCPMC7728696
OpenAlexW3047264699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.